Analysis of the transcriptional program of developing induced regulatory T cells

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Prots, Iryna ^a   Skapenko, Alla ^a   Lipsky, Peter E ^b   Schulze Koops, Hendrik ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXM1; TRANSCRIPTION FACTOR FOXO; UNCLASSIFIED DRUG; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4;

ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL CYCLE PROGRESSION; CELL FATE; CELL MATURATION; CONTROLLED STUDY; EFFECTOR CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; MICROARRAY ANALYSIS; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; CYTOLOGY; DRUG EFFECT; GENETIC TRANSCRIPTION; METABOLISM; SIGNAL TRANSDUCTION; TIME;

HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-4; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 79951799112     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016913     Document Type: Article

References (60)

1. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M, (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151-1164.
2. Shevach EM, (2002) CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2: 389-400.
3. von Boehmer H, (2005) Mechanisms of suppression by suppressor T cells. Nat Immunol 6: 338-344.
4. Sakaguchi S, (2004) Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22: 531-562.
5. Ziegler SF, (2006) FOXP3: of mice and men. Annu Rev Immunol 24: 209-226.
6. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, et al. (2004) Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200: 277-285.
7. Valencia X, Stephens G, Goldbach-Mansky R, Wilson M, Shevach EM, et al. (2006) TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood 108: 253-261.
8. Valencia X, Yarboro C, Illei G, Lipsky PE, (2007) Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 178: 2579-2588.
9. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA, (2004) Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199: 971-979.
10. Mottet C, Uhlig HH, Powrie F, (2003) Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 170: 3939-3943.
11. Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, et al. (2004) In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199: 1455-1465.
12. Morgan ME, Flierman R, van Duivenvoorde LM, Witteveen HJ, van Ewijk W, et al. (2005) Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum 52: 2212-2221.
13. Golshayan D, Jiang S, Tsang J, Garin MI, Mottet C, et al. (2007) In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance. Blood 109: 827-835.
14. van Mierlo GJ, Scherer HU, Hameetman M, Morgan ME, Flierman R, et al. (2008) Cutting edge: TNFR-shedding by CD4+CD25+ regulatory T cells inhibits the induction of inflammatory mediators. J Immunol 180: 2747-2751.
15. Sakaguchi S, Sakaguchi N, (2005) Regulatory T cells in immunologic self-tolerance and autoimmune disease. Int Rev Immunol 24: 211-226.
16. Jaeckel E, Kretschmer K, Apostolou I, von Boehmer H, (2006) Instruction of Treg commitment in peripheral T cells is suited to reverse autoimmunity. Semin Immunol 18: 89-92.
17. Lohr J, Knoechel B, Abbas AK, (2006) Regulatory T cells in the periphery. Immunol Rev 212: 149-162.
18. Pillai V, Karandikar NJ, (2007) Human regulatory T cells: a unique, stable thymic subset or a reversible peripheral state of differentiation? Immunol Lett 114: 9-15.
19. Curotto de Lafaille MA, Lafaille JJ, (2009) Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 30: 626-635.
20. Apostolou I, Verginis P, Kretschmer K, Polansky J, Huhn J, et al. (2008) Peripherally induced Treg: mode, stability, and role in specific tolerance. J Clin Immunol 28: 619-624.
21. Akbar AN, Vukmanovic-Stejic M, Taams LS, Macallan DC, (2007) The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery. Nat Rev Immunol 7: 231-237.
22. Gonzalez-Rey E, Chorny A, Delgado M, (2007) Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat Rev Immunol 7: 52-63.
23. Skapenko A, Kalden JR, Lipsky PE, Schulze-Koops H, (2005) The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors. J Immunol 175: 6107-6116.
24. Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA, (2007) IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol 178: 2018-2027.
25. Marson A, Kretschmer K, Frampton GM, Jacobsen ES, Polansky JK, et al. (2007) Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445: 931-935.
26. Josefowicz SZ, Rudensky A, (2009) Control of regulatory T cell lineage commitment and maintenance. Immunity 30: 616-625.
27. Hill JA, Feuerer M, Tash K, Haxhinasto S, Perez J, et al. (2007) Foxp3 transcription-factor-dependent and-independent regulation of the regulatory T cell transcriptional signature. Immunity 27: 786-800.
28. Rosenberg SA, Lipsky PE, (1979) Monocyte dependence of pokeweed mitogen-induced differentiation of immunoglobulin-secreting cells from human peripheral blood mononuclear cells. J Immunol 122: 926-931.
29. Skapenko A, Lipsky PE, Kraetsch HG, Kalden JR, Schulze-Koops H, (2001) Antigen-independent Th2 cell differentiation by stimulation of CD28: regulation via IL-4 gene expression and mitogen-activated protein kinase activation. J Immunol 166: 4283-4292.
30. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, et al. (2005) Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6: 1219-1227.
31. Apostolou I, von Boehmer H, (2004) In vivo instruction of suppressor commitment in naive T cells. J Exp Med 199: 1401-1408.
32. Chen W, Jin W, Hardegen N, Lei KJ, Li L, et al. (2003) Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198: 1875-1886.
33. Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, et al. (2004) Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172: 5149-5153.
34. Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ, (2007) All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 204: 1765-1774.
35. Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM, et al. (2007) A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 204: 1757-1764.
36. Mucida D, Pino-Lagos K, Kim G, Nowak E, Benson MJ, et al. (2009) Retinoic acid can directly promote TGF-beta-mediated Foxp3(+) Treg cell conversion of naive T cells. Immunity 30: 471-472; author reply 472-473.
37. Nolting J, Daniel C, Reuter S, Stuelten C, Li P, et al. (2009) Retinoic acid can enhance conversion of naive into regulatory T cells independently of secreted cytokines. J Exp Med 206: 2131-2139.
38. Hong J, Li N, Zhang X, Zheng B, Zhang JZ, (2005) Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc Natl Acad Sci U S A 102: 6449-6454.
39. Wang Z, Hong J, Sun W, Xu G, Li N, et al. (2006) Role of IFN-gamma in induction of Foxp3 and conversion of CD4+ CD25- T cells to CD4+ Tregs. J Clin Invest 116: 2434-2441.
40. Yagi H, Nomura T, Nakamura K, Yamazaki S, Kitawaki T, et al. (2004) Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 16: 1643-1656.
41. Pfoertner S, Jeron A, Probst-Kepper M, Guzman CA, Hansen W, et al. (2006) Signatures of human regulatory T cells: an encounter with old friends and new players. Genome Biol 7: R54.
42. Stockis J, Fink W, Francois V, Connerotte T, de Smet C, et al. (2009) Comparison of stable human Treg and Th clones by transcriptional profiling. Eur J Immunol 39: 869-882.
43. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, et al. (2009) Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30: 899-911.
44. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, et al. (2001) Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 193: 1285-1294.
45. Wang J, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Toes RE, (2007) Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 37: 129-138.
46. Cobbold SP, (2006) The hidden truth about gene expression in Tregs: is it what you don't see that counts? Eur J Immunol 36: 1360-1363.
47. Baecher-Allan C, Viglietta V, Hafler DA, (2004) Human CD4+CD25+ regulatory T cells. Semin Immunol 16: 89-98.
48. Hori S, Nomura T, Sakaguchi S, (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
49. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, et al. (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341.
50. Sauer S, Bruno L, Hertweck A, Finlay D, Leleu M, et al. (2008) T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci U S A 105: 7797-7802.
51. Haxhinasto S, Mathis D, Benoist C, (2008) The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J Exp Med 205: 565-574.
52. Crellin NK, Garcia RV, Levings MK, (2007) Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells. Blood 109: 2014-2022.
53. Burgering BM, Medema RH, (2003) Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J Leukoc Biol 73: 689-701.
54. Ouyang W, Beckett O, Ma Q, Paik JH, DePinho RA, et al. (2010) Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat Immunol 11: 618-627.
55. Harada Y, Elly C, Ying G, Paik JH, DePinho RA, et al. (2010) Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. J Exp Med 207: 1381-1391.
56. Ho KK, Myatt SS, Lam EW, (2008) Many forks in the path: cycling with FoxO. Oncogene 27: 2300-2311.
57. Seoane J, Le HV, Shen L, Anderson SA, Massague J, (2004) Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117: 211-223.
58. Delpuech O, Griffiths B, East P, Essafi A, Lam EW, et al. (2007) Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression. Mol Cell Biol 27: 4917-4930.
59. Wang IC, Chen YJ, Hughes D, Petrovic V, Major ML, et al. (2005) Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol 25: 10875-10894.
60. Laoukili J, Kooistra MR, Bras A, Kauw J, Kerkhoven RM, et al. (2005) FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol 7: 126-136.